165 related articles for article (PubMed ID: 38632349)
1. Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis.
Ghouse J; Sveinbjörnsson G; Vujkovic M; Seidelin AS; Gellert-Kristensen H; Ahlberg G; Tragante V; Rand SA; Brancale J; Vilarinho S; Lundegaard PR; Sørensen E; Erikstrup C; Bruun MT; Jensen BA; Brunak S; Banasik K; Ullum H; ; Verweij N; Lotta L; Baras A; ; Mirshahi T; Carey DJ; ; ; Kaplan DE; Lynch J; Morgan T; Schwantes-An TH; Dochtermann DR; Pyarajan S; Tsao PS; ; Laisk T; Mägi R; Kozlitina J; Tybjærg-Hansen A; Jones D; Knowlton KU; Nadauld L; Ferkingstad E; Björnsson ES; Ulfarsson MO; Sturluson Á; Sulem P; Pedersen OB; Ostrowski SR; Gudbjartsson DF; Stefansson K; Olesen MS; Chang KM; Holm H; Bundgaard H; Stender S
Nat Genet; 2024 May; 56(5):827-837. PubMed ID: 38632349
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
3. Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population.
Gellert-Kristensen H; Richardson TG; Davey Smith G; Nordestgaard BG; Tybjaerg-Hansen A; Stender S
Hepatology; 2020 Sep; 72(3):845-856. PubMed ID: 32190914
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
5. Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.
Emdin CA; Haas M; Ajmera V; Simon TG; Homburger J; Neben C; Jiang L; Wei WQ; Feng Q; Zhou A; Denny J; Corey K; Loomba R; Kathiresan S; Khera AV
Gastroenterology; 2021 Apr; 160(5):1620-1633.e13. PubMed ID: 33310085
[TBL] [Abstract][Full Text] [Related]
6. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC
Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
9. The ATG16L1 gene variant rs2241880 (p.T300A) is associated with susceptibility to HCC in patients with cirrhosis.
Reuken PA; Lutz P; Casper M; Al-Herwi E; Stengel S; Spengler U; Stallmach A; Lammert F; Nischalke HD; Bruns T
Liver Int; 2019 Dec; 39(12):2360-2367. PubMed ID: 31484215
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
[TBL] [Abstract][Full Text] [Related]
11. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
[TBL] [Abstract][Full Text] [Related]
12. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.
Singal AG; Manjunath H; Yopp AC; Beg MS; Marrero JA; Gopal P; Waljee AK
Am J Gastroenterol; 2014 Mar; 109(3):325-34. PubMed ID: 24445574
[TBL] [Abstract][Full Text] [Related]
13. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S
Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
Young KA; Palmer ND; Fingerlin TE; Langefeld CD; Norris JM; Wang N; Xiang AH; Guo X; Williams AH; Chen YI; Taylor KD; Rotter JI; Raffel LJ; Goodarzi MO; Watanabe RM; Wagenknecht LE
Obesity (Silver Spring); 2019 Aug; 27(8):1331-1337. PubMed ID: 31219225
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in
Buch S; Innes H; Lutz PL; Nischalke HD; Marquardt JU; Fischer J; Weiss KH; Rosendahl J; Marot A; Krawczyk M; Casper M; Lammert F; Eyer F; Vogel A; Marhenke S; von Felden J; Sharma R; Atkinson SR; McQuillin A; Nattermann J; Schafmayer C; Franke A; Strassburg C; Rietschel M; Altmann H; Sulk S; Thangapandi VR; Brosch M; Lackner C; Stauber RE; Canbay A; Link A; Reiberger T; Mandorfer M; Semmler G; Scheiner B; Datz C; Romeo S; Ginanni Corradini S; Irving WL; Morling JR; Guha IN; Barnes E; Ansari MA; Quistrebert J; Valenti L; Müller SA; Morgan MY; Dufour JF; Trebicka J; Berg T; Deltenre P; Mueller S; Hampe J; Stickel F
Gut; 2023 Feb; 72(2):381-391. PubMed ID: 35788059
[TBL] [Abstract][Full Text] [Related]
16. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
17. The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.
Innes H; Nischalke HD; Guha IN; Weiss KH; Irving W; Gotthardt D; Barnes E; Fischer J; Ansari MA; Rosendahl J; Lin SK; Marot A; Pedergnana V; Casper M; Benselin J; Lammert F; McLauchlan J; Lutz PL; Hamill V; Mueller S; Morling JR; Semmler G; Eyer F; von Felden J; Link A; Vogel A; Marquardt JU; Sulk S; Trebicka J; Valenti L; Datz C; Reiberger T; Schafmayer C; Berg T; Deltenre P; Hampe J; Stickel F; Buch S
Hepatol Commun; 2022 May; 6(5):1213-1226. PubMed ID: 34958182
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
[TBL] [Abstract][Full Text] [Related]
20. The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.
Balasus D; Way M; Fusilli C; Mazza T; Morgan MY; Cervello M; Giannitrapani L; Soresi M; Agliastro R; Vinciguerra M; Montalto G
Oncotarget; 2016 Dec; 7(52):86791-86802. PubMed ID: 27888630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
